Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells

Biochemical and Biophysical Research Communications

Volumn 362, Issue 2, 2007, Pages 368-373

  Mikami, Yoshikazu ^a   Omoteyama, Kazuki ^a   Kato, Shigeyuki ^a   Takagi, Minoru ^a  

^a Dental Research Center   (Japan)

Author keywords

Dexamethasone; Mineralization; ROS17 2.8; Runx2

Indexed keywords

ALIZARIN RED S; BIOLOGICAL MARKER; CALCIUM; CYCLOHEXIMIDE; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; SIALOPROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MARKER GENE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ALKALINE PHOSPHATASE; ANIMALS; ANTHRAQUINONES; BLOTTING, WESTERN; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL DIFFERENTIATION; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GLUCOCORTICOIDS; HISTOCYTOCHEMISTRY; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIALOGLYCOPROTEINS; TIME FACTORS; TRANSFECTION;

EID: 34548264631     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.192     Document Type: Article

References (19)

1. Lian J.B., Shalhoub V., Aslam F., Frenkel B., Green J., Hamrah M., Stein G.S., and Stein J.L. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 138 (1997) 2117-2127
2. Estell R. Management of corticosteroid-induced osteoporosis. J. Intern. Med. 237 (1995) 439-447
3. Patschan D., Loddenkemper K., and Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29 (2001) 498-505
4. Canalis E., and Delany A.M. Mechanisms of glucocorticoid action in bone. Ann. N.Y. Acad. Sci. 966 (2002) 73-81
5. Leboy P.S., Beresford J.N., Devlin C., and Owen M.E. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J. Cell. Physiol. 146 (1991) 370-378
6. Smith E., Redman R.A., Logg C.R., Coetzee G.A., Kasahara N., and Frenkel B. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. J. Biol. Chem. 275 (2000) 19992-20001
7. (2 +)-ATPase inhibitor thapsigargin. Exp. Cell Res. 212 (1994) 84-92
8. Pockwinse S.M., Stein J.L., Lian J.B., and Stein G.S. Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: interrelationship of morphology and gene expression by in situ hybridization. Exp. Cell Res. 216 (1995) 244-260
9. Ogata Y., Yamauchi M., Kim R.H., Li J.J., Freedman L.P., and Sodek J. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur. J. Biochem. 230 (1995) 183-192
10. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
11. Ducy P., Zhang R., Geoffroy V., and Ridall A.L. Karsenty GOsf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
12. Partridge N.C., Alcorn D., Michelangeli V.P., Ryan G., and Martin T.J. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res. 43 (1983) 4308-4314
13. Ishida Y., and Heersche J.N. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J. Bone Miner. Res. 13 (1998) 1822-1828
14. Hunter G.K., and Goldberg H.A. Nucleation of hydroxyapatite by bone sialoprotein. Proc. Natl. Acad. Sci. USA 90 (1993) 8562-8565
15. McKee M.D., Nanci A., and Khan S.R. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J. Bone Miner. Res. 12 (1995) 1913-1929
16. Kern B., Shen J., Starbuck M., and Karsenty G. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J. Biol. Chem. 276 (2001) 7101-7107
17. Mori K., Shioi A., Jono S., Nishizawa Y., and Morii H. Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2112-2118
18. Wee H.J., Haung G., Shigesada K., and Ito Y. Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms. EMBO Rep. 3 (2002) 967-974
19. Phillips J.E., Gersbach C.A., Wojtowicz A.M., and Garcia A.J. Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J. Cell Sci. 119 (2006) 581-591